Unclaimed Scholar Profile
Are you Marc Mendelson? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of Cape TownASIDASID-8251-8594-2756 orcid.org/0000-0001-6668-3893
Marc Mendelson
University of Cape Town•South Africa
Faculty researcher at University of Cape Town (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Antibiotic Use and Resistance#Antibiotic Resistance in Bacteria#Infection Control in Healthcare#Tuberculosis Research and Epidemiology
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 20,654 | 9,914 |
| h-index | 62 | 47 |
| i10-index | 147 | 103 |
Annual Citation Growth
Verified Citations / Year0
2020991
2021+40%1.4k
2022+29%1.8k
2023+33%2.4k
2024-8%2.2k
2025-45%1.2k
2026Scholarship Distribution & Proportions305 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (16,936) • 18% Global Research Impact (3,718)
305 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (305)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
DOI: 10.1016/s1473-3099(17)30753-3 Verified Peer-Reviewed
The World Health Organization Global Action Plan for antimicrobial resistance
DOI: 10.7196/samj.9644 Verified Peer-Reviewed
A living WHO guideline on drugs for covid-19 (2020-2023)
Published in BMJ•2020
DOI: 10.1136/bmj.m3379 Verified Peer-Reviewed
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
Published in JAMA•2018
DOI: 10.1001/jama.2018.12163 Verified Peer-Reviewed
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
Published in Clinical Infectious Diseases•2020
DOI: 10.1093/cid/ciaa1198 Verified Peer-Reviewed
Showing 1 – 5 of 305 publications
1 / 61